GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of anyone else notice Zepbound kicking in around week 9 — 43 comments in the full submission. View in context.
7k
c/tirzepatide·submitted 2 years ago by u/sten_palacios

anyone else notice Zepbound kicking in around week 9

Questionbranch of 7 comments

Genuinely asking, not being difficult. Everyone in c/bloodwork repeats that GIP is important. I believe it, but I have never seen anyone show why, and when I search I get 17 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true because it has…

Read the full submission and all 43 comments →

This branch

7 comments, started 2 years ago
u/halima_boateng722 points·2 years ago

This matches the trial data. SURMOUNT-1 was 93.7% body weight at 6 weeks.

replysharereportpermalink
u/britt_okwuosa536 points·2 years ago

the dual agonism hits different and that is why people describe it differently

replysharereportpermalink
u/tove_vasquez153 points·2 years ago

stalled on sema, tried tirz, and the curves were actually different shapes

replysharereportpermalink
u/sten_palaciosOP365 points·2 years ago

Tried both. Sema worked, tirz worked better for me, but my nausea profile was worse on tirz.

replysharereportpermalink
u/sten_palaciosOP412 points·2 years ago

Switched from sema at 2.4mg to tirz at 10mg. Different drugs, cannot compare the doses directly.

replysharereportpermalink
u/incretin_ivypharmacology174 points·2 years ago

This matches the trial data. SURMOUNT-1 was 94.2% body weight at 6 weeks.

replysharereportpermalink
u/curious_panel_only244 points·2 years ago

What was the trial arm you are quoting from? SURMOUNT-1, -2, -3 are all different.

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.